连续性血液净化联合血液灌流在儿童溶血尿毒综合征中的应用

朱颖,董扬,徐达良,江家云

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (1) : 53-55.

PDF(905 KB)
PDF(905 KB)
中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (1) : 53-55. DOI: 10.7499/j.issn.1008-8830.2013.01.014
论著·临床研究

连续性血液净化联合血液灌流在儿童溶血尿毒综合征中的应用

  • 朱颖,董扬,徐达良,江家云
作者信息 +

Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children

  • ZHU Ying, DONG Yang, XU Da-Liang, JIANG Jia-Yun
Author information +
文章历史 +

摘要

目的:观察连续性血液净化(CBP)联合血液灌流(HP)治疗儿童溶血尿毒综合征(HUS)的疗效并初步探讨其治疗的可能机制。方法:在内科治疗基础上,急性期均采用CBP联合HP治疗HUS患儿8例。治疗前后采用化学发光法检测血清IL-6、IL-8、TNF-α水平,并测定血尿素氮(BUN)、肌酐(SCr)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、肌酸激酶(CK)、肌酸激酶同工酶(CKMB)、血红蛋白(Hb)、血小板(PLT)、C反应蛋白(CRP)等水平。8例健康体检儿童作为对照组。结果:经CBP联合HP治疗后,8例HUS患儿均存活,病情好转;Hb、PLT水平较治疗前回升, 血清IL-6、IL-8、TNF-α、BUN、SCr、ALT、CK、CRP水平较治疗前下降,差异有统计学意义(P<0.05)。结论:CBP联合HP治疗能迅速清除致病因子,又能持续清除炎症介质和毒素,逆转多脏器功能障碍,是治疗儿童HUS的有效方法之一。

Abstract

OBJECTIVE: To observe the therapeutic effect of continuous blood purification (CBP) combined with hemoperfusion (HP) in children with hemolytic-uremic syndrome (HUS) and to investigate its possible mechanism. METHODS: Eight children with HUS received CBP combined with HP on the basis of internal medicine treatment in the acute stage. Before and after treatment, serum levels of interleukin-6 (IL-6), IL-8 and tumor necrosis factor-α (TNF-α) were measured by chemiluminescence method, and levels of blood urea nitrogen (BUN), serum creatinine (SCr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), creatine kinase MB (CKMB), hemoglobin (Hb), platelet (PLT) and C-reactive protein (CRP) were measured. Eight healthy children undergoing physical examination were used as controls. RESULTS: The 8 children with HUS all survived after CBP combined with HP and showed improved conditions. They had increased Hb and PLT levels and decreased serum levels of IL-6, IL-8, TNF-α, BUN, SCr, ALT, CK and CRP after treatment (P<0.05). CONCLUSIONS: CBP combined with HP can quickly remove pathogenic factors, continually eliminate inflammatory mediators and toxins, and reverse multiple organ dysfunction, and is one of effective methods for treating HUS in children.

关键词

溶血尿毒综合征 / 连续性肾脏替代治疗 / 血液灌流 / 儿童

Key words

Hemolytic-uremic syndrome / Continuous blood purification / Hemoperfusion / Child

引用本文

导出引用
朱颖,董扬,徐达良,江家云. 连续性血液净化联合血液灌流在儿童溶血尿毒综合征中的应用[J]. 中国当代儿科杂志. 2013, 15(1): 53-55 https://doi.org/10.7499/j.issn.1008-8830.2013.01.014
ZHU Ying, DONG Yang, XU Da-Liang, JIANG Jia-Yun. Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(1): 53-55 https://doi.org/10.7499/j.issn.1008-8830.2013.01.014

参考文献

[1]赵季琳.溶血尿毒综合征[M]//胡亚美,江载芳. 诸福堂实用儿科学(下册). 第7版. 北京:人民卫生出版社,2002:1659-1662.

[2]Santiago MJ, López-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, et al.Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy[J]. Intensive Care Med, 2010, 36(5): 843-849.

[3]Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, et al. Shiga toxin 2 targets the murine renal collecting duct epithelium[J]. Infect Immun, 2009, 77(3): 959-969.

[4]Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction[J]. Pediatr Nephrol, 2010, 25(11): 2231-2240.

[5]Stahl AL, Sartz L, Karpman D.Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytid uremic syndrome[J]. Blood, 2011, 117(20): 5503-5513.

[6]George JN, Terrell DR, Swisher KK, Vesely SK.Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry[J].J Clin Apher, 2008, 23(4): 129-137.

[7]Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP.Advances in understanding of pathogenesis of aHUS and HELLP[J]. Br J Haematol, 2008, 143(3): 336-348.

[8]Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, et al. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP[J]. Pediatr Nephrol, 2012, 27(1): 73-81.

[9]Johnson S, Waters A.Is complements a culprit in infection-induced forms of haemolytic uraemic syndrome?[J]. Immunobiology, 2011, 26. [Epub ahead of print].

[10]王质刚 .血液净化新概念: 血液净化理论与技术的新进展[J].中国血液净化, 2008,7(2): 59-60.

[11]Chen ZH, Liu ZH, Yu C, Ji DX, Li LS.Endothelial dysfunction in patients with severe acute pancreatitis:improved by continuous blood purification therapy[J].Int J Artif organs, 2007, 30(5): 393-400.

[12]Tsuchida K, Yoshimura R, Nakatani T, Takemoto Y. Blood purification for critical  illness: cytokines adsorption therapy[J]. Ther Apher Dial, 2006, 10(1): 25-31.

[13]朱颖,董扬,徐达良,江家云,徐媛.连续性血液净化在儿童危重症中的应用[J]. 中国当代儿科杂志,2012,14(2):147-149. 


PDF(905 KB)

Accesses

Citation

Detail

段落导航
相关文章

/